These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34192842)

  • 1. [Meta-analysis of annual probability of outcome for different cervical disease states].
    You TT; Xia CF; Chen M; Qiao YL; Zhao FH
    Zhonghua Yi Xue Za Zhi; 2021 Jun; 101():1899-1907. PubMed ID: 34192842
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of Virus Genotypes in Machine Learning Diagnostic Prediction Models for Cervical Cancer in Women With High-Risk Human Papillomavirus Infection.
    Xiao T; Wang C; Yang M; Yang J; Xu X; Shen L; Yang Z; Xing H; Ou CQ
    JAMA Netw Open; 2023 Aug; 6(8):e2326890. PubMed ID: 37531108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: A 15-year population-based cohort study from China.
    Hu SY; Rezhake R; Chen F; Zhang X; Pan QJ; Ma JF; Qiao YL; Zhao FH
    Gynecol Oncol; 2020 Mar; 156(3):616-623. PubMed ID: 31937451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer.
    Barrett JE; Sundström K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M
    Genome Med; 2022 Oct; 14(1):116. PubMed ID: 36258199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
    Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
    Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation analysis of host genes in cervical intraepithelial neoplasia and cervical cancers on histological cervical specimens.
    Shi L; Yang X; He L; Zheng C; Ren Z; Warsame JA; Suye S; Yan L; Cai H; Xiao X; Fu C
    BMC Cancer; 2023 Feb; 23(1):168. PubMed ID: 36803573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3.
    Syrjänen K; Shabalova I; Naud P; Derchain S; Sarian L; Kozachenko V; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Branca M; Grunjberga V; Erzen M; Juschenko A; Hammes LS; Costa S; Podistov J; Syrjänen S; ; ;
    Int J STD AIDS; 2011 May; 22(5):263-72. PubMed ID: 21571974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of RBC and Serum Folate Concentrations with Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Genotypes in Female Chinese Adults.
    Wang W; Yang A; Zhang H; Li Y; Yang J; Zhao W; Wang Z; Lou H; Wang W; Liang T; Zhang L; Su X; Wang C; Wang J; Song J; Li L; Lv W; Zhao C; Hao M
    J Nutr; 2022 Feb; 152(2):466-474. PubMed ID: 35051275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more.
    Siebers AG; van der Linden H; Vedder JEM; Bekkers RLM; Melchers WLG; Bulten J
    Cytopathology; 2018 Jun; 29(3):275-280. PubMed ID: 29575519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
    Bukowski A; Hoyo C; Hudgens MG; Brewster WR; Valea F; Bentley RC; Vidal AC; Maguire RL; Schmitt JW; Murphy SK; North KE; Smith JS
    Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1564-1571. PubMed ID: 35654413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
    Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
    BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy.
    Yan L; Xiao X; He L; Shi L; Yang X; Zhang J; Zhang Y; Fu C
    PLoS One; 2023; 18(3):e0282833. PubMed ID: 36913396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population fraction of cervical neoplasia attributable to high-risk human papillomaviruses.
    Laukkanen P; Läärä E; Koskela P; Pukkala E; Virkkunen H; Lehtinen M
    Future Oncol; 2010 May; 6(5):709-16. PubMed ID: 20465386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
    De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
    van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
    Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models.
    Syrjänen K; Shabalova I; Sarian L; Naud P; Longatto-Filho A; Derchain S; Kozachenko V; Zakharchenko S; Roteli-Martins C; Nerovjna R; Kljukina L; Tatti S; Branovskaja M; Branca M; Grunjberga V; Erzen M; Juschenko A; Serpa Hammes L; Podistov J; Costa S; Syrjänen S; ;
    Eur J Gynaecol Oncol; 2012; 33(1):5-14. PubMed ID: 22439398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays.
    Dippmann C; Schmitz M; Wunsch K; Schütze S; Beer K; Greinke C; Ikenberg H; Hoyer H; Runnebaum IB; Hansel A; Dürst M
    Clin Epigenetics; 2020 Nov; 12(1):171. PubMed ID: 33176878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
    Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.